Shire Investors Say AbbVie Can't Ax Suit Over Failed Inversion
By Jeff Zalesin · May 19, 2015, 5:45 PM EDT
A putative class of Shire PLC shareholders said Monday that AbbVie Inc. must face claims that it harmed investors by downplaying the tax incentives for the drugmakers' $55 billion merger, which...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login